• linkedin
  • Increase Font
  • Sharebar

    How would MedPAC replace MIPS?

    Proposed alternative would act as an ‘on-ramp’ for joining Advanced APMs

    Bob GattyBob GattyIf the Medicare Payment Advisory Commission (MedPAC) has its way with Congress, urologists and other Medicare providers will be subjected to a new payment system, replacing the Merit-based Incentive Payment System (MIPS) that was established when the sustainable growth rate formula was ditched in 2015.

    On Jan. 11, MedPAC voted 14-2 to repeal and replace MIPS, one of two payment tracks physicians must follow under the Medicate Access and CHIP Reauthorization Act of 2015. The second is to participate in advanced alternative payment models (AAPMs), such as accountable care organizations.

    Also by Bob Gatty: Proposed bill targets prostate cancer misdiagnoses

    Under the new program recommended by MedPAC, MIPS would be replaced with a new “Voluntary Value Program” in which clinicians join a group and are compared to each other based on quality of care for patients. Physicians who do well under that scenario would receive an incentive payment.

    “I applaud their recognition that the rollout and education for practices to competently follow the MIPS metrics and reporting was not straightforward and simple,” said LUGPA President Neal D. Shore, MD. “It has certainly caused a great deal of additional work for many practices and also anxiety for many clinicians.”

    Dr. Shore told Urology Times that the goal of improving value-based care and quality outcomes has always been supported by LUGPA, adding that “any new improvement in a new model should strive for the same goals, but with added simplicity.”

    Next: Proposal 'hard to understand'

    Bob Gatty
    Bob Gatty, a former congressional aide, covers news from Washington for Urology Times.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available